Europe real estate
Scope
Date
~
-
Pension funds
S.Korea’s GEPS to commit $143 million to foreign mid-cap buyout funds
The Government Employees Pension Service (GEPS), one of South Korea’s top three public pension programs, will commit up to 200 billion won ($1...
May 08, 2025 (Gmt+09:00)
-
Bio & Pharma
Korea’s pharmaceutical exports set to top $10 bn, led by ‘K-M7’ champions
South Korea’s pharmaceutical exports are on course to surpass $10 billion this year, underscoring the country’s growing clout in the glo...
May 05, 2025 (Gmt+09:00)
-
Real estate
Mirae Asset to be named Korea Post’s core real estate fund operator
Mirae Asset Global Investments Co. is set to manage the mandate of more than 600 billion won ($416.8 million) in core real estate fund investment by...
Apr 29, 2025 (Gmt+09:00)
-
Batteries
LG Energy Solution clinches multibillion-dollar ESS deals in Japan, Europe
LG Energy Solution Ltd. has secured a string of billion-dollar energy storage system (ESS) deals in Japan and Europe, outmaneuvering Chinese rivals ...
Apr 15, 2025 (Gmt+09:00)
-
Real estate
Mirae, Koramco, Hana shortlisted for Korea Post’s core real estate fund
Mirae Asset Global Investments Co., Koramco REITs Management and Trust Co. and Hana Alternative Asset Management Co. were shortlisted for the mandat...
Apr 14, 2025 (Gmt+09:00)
-
Private equity
Glenwood PE to increase blind fund to $1 bn on pension funds’ interest
South Korea’s Glenwood Private Equity Co. is set to increase a blind fund to 1.5 trillion won ($1 billion) as pension funds at home and abroad...
Apr 11, 2025 (Gmt+09:00)
-
Alternative investments
Korean financial firms face growing risks in overseas property investments
South Korea’s financial institutions are increasingly at risk of their overseas real estate investments turning sour, government data showed o...
Apr 04, 2025 (Gmt+09:00)
-
Real estate
Asia Property to buy WeWork building in Seoul
Seoul-based real estate investment firm Asia Property has been picked as the sole preferred bidder for an office building currently occupied by cowo...
Apr 04, 2025 (Gmt+09:00)
-
Asset management
Strong momentum in non-US markets, digital real estate: Principal AM CEO
It is time to shift focus toward non-US markets after years of stellar performance of US assets driven by the robust world’s No. 1 economy, sa...
Apr 02, 2025 (Gmt+09:00)
-
Real estate
Global real estate market poised for strong rebound: Savills
The global real estate market is expected to pick up significantly over the next few years, with around $500 billion worth of real estate assets, he...
Mar 12, 2025 (Gmt+09:00)
-
Bio & Pharma
Samsung, Celltrion lead biosimilar market in Europe, US
Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...
Mar 10, 2025 (Gmt+09:00)
-
Electric vehicles
Hyundai, Kia ready to ramp up EV output in Europe, US
South Korea’s top two automakers Hyundai Motor Co. and Kia Corp. are expected to ramp up electric vehicle production in Europe and the US to b...
Mar 06, 2025 (Gmt+09:00)
-
Real estate
European student housing is top of the class: Savills IM
The appeal of European purpose-built student accommodation (PBSA) to real estate investors is growing rapidly. In the recent 2025 INREV Investor Int...
Mar 06, 2025 (Gmt+09:00)
-
Electric vehicles
Kia CEO stands firm on electrification strategy, premieres EV4 in Europe
TARRAGONA, Spain – Despite a temporary slowdown in electric vehicle demand and intensifying competition from Chinese automakers, Kia Corp. rem...
Feb 27, 2025 (Gmt+09:00)
-
Alternative investments
S.Korean investors name their 33 favorite alternative asset managers
Blackstone and HarbourVest Partners are South Korean institutional investors’ preferred private equity firms, according to a survey by Korea I...
Feb 27, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins EU approval for autoimmune disease treatment Avtozma
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
Feb 25, 2025 (Gmt+09:00)
-
Alternative investments
KIC explores Europe middle-market private equity opportunities
The Korea Investment Corporation (KIC) on Monday explored investment opportunities in Europe’s middle-market private equity sector with other ...
Feb 25, 2025 (Gmt+09:00)
-
Real estate
PAG raises $4 bn for opportunistic Asia real estate fund
PAG, an Asia Pacific-focused alternative investment firm, on Friday announced the final close of its 10th opportunistic real estate fund at $4 billi...
Feb 14, 2025 (Gmt+09:00)
-
Medical devices
Middle East: New land of opportunity for Korean medical devices
South Korea is making inroads into the Middle East's medical device market dominated by the US and Europe, aiming to leverage the region’s str...
Feb 10, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe
South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...
Feb 05, 2025 (Gmt+09:00)
-
Real estate
Blackstone zooms in on hotels, warehouses in Korea
The global real estate market is poised for a recovery, led by industrial warehouses, residential facilities and data centers benefiting from declin...
Jan 21, 2025 (Gmt+09:00)
-
Real estate
NPS commits $800 mn to Almanac for strategic partnership
The National Pension Service of Korea (NPS) has committed $800 million to Almanac Realty Investors, the private real estate investment arm of Neuber...
Jan 16, 2025 (Gmt+09:00)
-
Private debt
Real estate debt outshines corporate credit: Savills IM
Private credit has been among the top picks for alternative investors over the past few years. During the period of high interest rates, corporate l...
Jan 14, 2025 (Gmt+09:00)
-
Energy
SK Energy, Korea’s first refiner to export sustainable aviation fuel to Europe
SK Energy Co., South Korea’s largest oil refiner, said on Sunday it has shipped its first batch of sustainable aviation fuel (SAF) to Europe, ...
Jan 05, 2025 (Gmt+09:00)
-
Bio & Pharma
Korean drugmakers control more than half of European biosimilar market
South Korea’s two leading drugmakers, Celltrion Inc. and Samsung Bioepis Co., have achieved a significant milestone in the European biosimilar...
Jan 02, 2025 (Gmt+09:00)
-
Bio & Pharma
Yuhan’s lung cancer drug gets OK in Europe
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Dec 31, 2024 (Gmt+09:00)
-
Food & Beverage
S.Korea's office cafeteria firms expand into overseas markets
South Korea's office cafeteria companies, including Hyundai Green Food Co., Ourhome, and Samsung Welstory plan to expand overseas markets with the p...
Dec 30, 2024 (Gmt+09:00)
-
Automobiles
Kia aims to reclaim Europe with EV2, keeps K4 output unchanged in Mexico
Kia Corp., South Korea’s second-largest carmaker, will start producing its entry-level electrified model EV2 from its plant in Slovakia next y...
Dec 23, 2024 (Gmt+09:00)
-
Korean startups
Bering Lab eyes 7-fold jump in revenue in 5 years
Bering Lab Inc., a South Korea-based artificial intelligence technology-powered translation startup with specialties in legal, financial and intelle...
Nov 21, 2024 (Gmt+09:00)
-
Korean food
CJ CheilJedang to invest $584 mn to build food factories in Europe, US
CJ CheilJedang Corp., South Korea’s largest food company, will spend a total of $584 million to build new food-manufacturing factories in Euro...
Nov 21, 2024 (Gmt+09:00)